Skip to main content
FMHS
OTC Technology

Going Concern Warning, Material Weaknesses, and Massive Dilution Risk Highlighted in Annual Report

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$0.165
Mkt Cap
$3.113M
52W Low
$0
52W High
$1.5
Market data snapshot near publication time

summarizeSummary

FARMHOUSE, INC.'s annual report reveals substantial doubt about its ability to continue as a going concern, material weaknesses in internal controls, and a highly dilutive $20 million equity financing facility, alongside minimal revenue and increasing debt.


check_boxKey Events

  • Going Concern Warning Issued

    Both management and the independent auditor have expressed substantial doubt about the company's ability to continue as a going concern due to recurring losses, negative cash flow from operations, and a significant stockholders' deficit of $(2,674,429) as of December 31, 2025.

  • Material Weaknesses in Internal Controls Identified

    Management concluded that internal control over financial reporting was not effective as of December 31, 2025, citing a lack of defined internal control structure and insufficient accounting resources with SEC reporting expertise.

  • Massive Potential Dilution from Equity Line

    The company has an effective $20.0 million equity financing agreement with GHS Investments LLC, which could lead to substantial future dilution as shares are sold into the market. If all authorized shares were issued, dilution would be 1443.0%.

  • Heavy Reliance on Dilutive Convertible Debt

    Convertible notes payable increased significantly to $536,172 in 2025, with many notes in default. The company also recognized $89,455 in derivative liabilities for embedded conversion features, indicating complex and potentially dilutive terms.


auto_awesomeAnalysis

FARMHOUSE, INC.'s annual report reveals a critical financial state, with both management and auditors expressing substantial doubt about the company's ability to continue as a going concern. This is compounded by material weaknesses in internal controls, indicating significant operational and financial reporting risks. The company continues to operate with minimal revenue and increasing cash burn from operations, relying heavily on dilutive financing. The $20 million equity financing facility, now effective, represents a massive potential dilution, and the company's digital asset strategy remains highly speculative with no assets acquired or concrete plans. Investors should be aware of the severe financial distress and high risk associated with this company.

At the time of this filing, FMHS was trading at $0.16 on OTC in the Technology sector, with a market capitalization of approximately $3.1M. The 52-week trading range was $0.00 to $1.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed FMHS - Latest Insights

FMHS
Apr 17, 2026, 1:39 PM EDT
Filing Type: 10-K
Importance Score:
9
FMHS
Jan 16, 2026, 7:27 PM EST
Filing Type: S-1/A
Importance Score:
9
FMHS
Jan 08, 2026, 4:10 PM EST
Filing Type: S-1
Importance Score:
9